title: Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European survey.
authors.affiliation: .
authors.forename: Tuukka A
authors.initials: TA
authors.lastname: Helin
authors.affiliation: .
authors.forename: Anja
authors.initials: A
authors.lastname: Pakkanen
authors.affiliation: .
authors.forename: Riitta
authors.initials: R
authors.lastname: Lassila
authors.affiliation: .
authors.forename: Lotta
authors.initials: L
authors.lastname: Joutsi-Korhonen
mesh_terms: D002138:Calibration; D005060:Europe; D065427:Factor Xa Inhibitors / Q000032:analysis* / Q000592:standards; D006801:Humans; D019934:International Normalized Ratio / Q000592:standards; D007753:Laboratories / Q000592:standards; D010314:Partial Thromboplastin Time / Q000592:standards*; D011517:Prothrombin Time / Q000592:standards*; D011720:Pyrazoles / Q000032:analysis* / Q000592:standards; D011728:Pyridones / Q000032:analysis* / Q000592:standards; D011795:Surveys and Questionnaires
chemical_list: D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban
keywords: EQA; LMWH calibration; anti-Xa; anticoagulant; apixaban